AstraZeneca and Roche Diagnostics Asia Pacific today announced a three-year Memorandum of Understanding to help advance ...
NeoRad(Low): A phase 2 trial of neoadjuvant (NA) ipilimumab + nivolumab (ipi+nivo) with low dose stereotactic body radiation therapy (SBRT) as an immune stimulant in patients with resectable stage ...
Effects of immediate elevation of inflammatory cytokines after platinum, pemetrexed, and pembrolizumab on antitumor efficacy in advanced non-squamous, non-small cell lung cancer. Unraveling relatlimab ...
We used the Surveillance, Epidemiologic, and End Results (SEER) database to determine the incidence of SCLC over the last 30 years. In addition, we sought to determine sex- and stage-based differences ...
Oncology experts from all over the world will discuss the latest developments in care. ASCO bills its 2026 meeting as “the ...
Collecting BMI data could further research into why women with lung cancer have better survival outcomes than men.An ...
For nearly half of people diagnosed with lung cancer, immunotherapy can slow the disease but not stop it. Funded through a $4 million joint investment from the Canadian Cancer Society (CCS) and the ...
"We found a significant association of genetically estimated sensitivity to environmental stress and adversity in relation to lung cancer risk among individuals of European ancestry, as well as in a ...
Lung adenocarcinoma is the most common type of lung cancer diagnosed in the U.S. Just over half of all non-small-cell lung cancers (NSCLCs) are adenocarcinomas. Finding out that you're at risk of lung ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results